GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lumos Diagnostics Holdings Ltd (OTCPK:LDXHF) » Definitions » Dividend Payout Ratio

LDXHF (Lumos Diagnostics Holdings) Dividend Payout Ratio : 0.00 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Lumos Diagnostics Holdings's Dividend Payout Ratio for the months ended in Dec. 2024 was 0.00.

The historical rank and industry rank for Lumos Diagnostics Holdings's Dividend Payout Ratio or its related term are showing as below:


LDXHF's Dividend Payout Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.41
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2025-03-24), the Dividend Yield % of Lumos Diagnostics Holdings is 0.00%.

Lumos Diagnostics Holdings's Dividends per Share for the months ended in Dec. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Lumos Diagnostics Holdings Dividend Payout Ratio Historical Data

The historical data trend for Lumos Diagnostics Holdings's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Dividend Payout Ratio Chart

Lumos Diagnostics Holdings Annual Data
Trend Jun22 Jun23 Jun24
Dividend Payout Ratio
- - -

Lumos Diagnostics Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Dividend Payout Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of Lumos Diagnostics Holdings's Dividend Payout Ratio

For the Medical Devices subindustry, Lumos Diagnostics Holdings's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumos Diagnostics Holdings's Dividend Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lumos Diagnostics Holdings's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's Dividend Payout Ratio falls into.


Lumos Diagnostics Holdings Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Lumos Diagnostics Holdings's Dividend Payout Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Jun. 2024 )/ EPS without NRI (A: Jun. 2024 )
=0/ -0.016
=N/A

Lumos Diagnostics Holdings's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2024 )/ EPS without NRI (Q: Dec. 2024 )
=0/ -0.005
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumos Diagnostics Holdings (OTCPK:LDXHF) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Lumos Diagnostics Holdings Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lumos Diagnostics Holdings Ltd (OTCPK:LDXHF) » Definitions » Dividend Payout Ratio
Comparable Companies
ASX:UBI ASX:OSL ASX:HMD ASX:AT1 ASX:EYE ASX:CBL ASX:CSX ASX:ADRDA ASX:UCM ASX:IRX ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
LDX:Australia
Address
2724 Loker Avenue West, Carlsbad, CA, USA, 92010
Website
https://www.lumosdiagnostics.com
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services, and it operates across two geographical regions, the United States and Australia. and the majority of revenue is generated from the United States.

Lumos Diagnostics Holdings Headlines

From GuruFocus

Lumos Diagnostics Receives Authorization for CoviDx� SARS-CoV-2 Rapid Antigen Test in Canada

By Business Wire Business Wire • 11-03-2021

Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser

By Business Wire Business Wire • 09-14-2021

Economic Evaluation of Lumos Diagnostics' FebriDx� Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually

By Business Wire Business Wire • 10-06-2021

Lumos Diagnostics FY21 Full Year Results

By Business Wire Business Wire • 08-31-2021

Lumos Diagnostics Raises $63M AUD in ASX IPO

By Business Wire Business Wire • 07-08-2021